; and (B) consider whether to include with the determination under subparagraph (A) a separate determination on whether a revision of the Mandatory Guidelines for Federal Workplace Drug Testing Programs to expand the list of substances authorized for testing to include any other drugs or other substances listed in schedule I and II of section 202 of the Controlled Substances Act ( 21 U.S.C. 812 ) is justified based on the criteria described in subparagraph (A). (2) Revision of guidelines If an expansion of the substance list is determined to be justified under paragraph (1), the Secretary of Health and Human Services shall— (A) notify the Committee on Commerce, Science, and Transportation of the Senate and the Committee on Transportation and Infrastructure of the House of Representatives of the determination